Merriman Curhan Ford maintains a 'Buy' on Cyclacel Pharmaceuticals (Nasdaq: CYCC), price target range $7-8.

Merriman analyst says, " Recall ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE